P1125: CELESTIMO: A PHASE III TRIAL EVALUATING THE EFFICACY AND SAFETY OF MOSUNETUZUMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA

Nastoupil, Loretta; Morschhauser, Franck; Scholz, Christian W.; Bishton, Mark; Yoon, Sung-Soo; Giri, Pratyush; wei, Michael C.; Knapp, Andrea; Li, Chi Chi; Bottos, Alessia; Li, haocheng; Purev, Enkhtsetseg; Bartlett, Nancy L.

doi:10.1097/01.HS9.0000847368.92731.fb

P1125: CELESTIMO: A PHASE III TRIAL EVALUATING THE EFFICACY AND SAFETY OF MOSUNETUZUMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA

Nastoupil, Loretta; Morschhauser, Franck; Scholz, Christian W.; Bishton, Mark; Yoon, Sung-Soo; Giri, Pratyush; wei, Michael C.; Knapp, Andrea; Li, Chi Chi; Bottos, Alessia; Li, haocheng; Purev, Enkhtsetseg; Bartlett, Nancy L.

Authors

Loretta Nastoupil

Franck Morschhauser

Christian W. Scholz

Mark Bishton

Sung-Soo Yoon

Pratyush Giri

Michael C. wei

Andrea Knapp

Chi Chi Li

Alessia Bottos

haocheng Li

Enkhtsetseg Purev

Nancy L. Bartlett

Citation

Nastoupil, L., Morschhauser, F., Scholz, C. W., Bishton, M., Yoon, S., Giri, P., …Bartlett, N. L. (2022). P1125: CELESTIMO: A PHASE III TRIAL EVALUATING THE EFFICACY AND SAFETY OF MOSUNETUZUMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA. HemaSphere, 6(S3), 1015-1016. https://doi.org/10.1097/01.HS9.0000847368.92731.fb

Journal Article Type	Other
Conference Name	EHA2022 Congress
Conference Location	Vienna, Austria and online
Acceptance Date	Jun 1, 2022
Publication Date	2022-06
Deposit Date	Aug 1, 2023
Publicly Available Date	Aug 3, 2023
Journal	HemaSphere
Electronic ISSN	2572-9241
Publisher	Ovid Technologies (Wolters Kluwer Health)
Peer Reviewed	Peer Reviewed
Volume	6
Issue	S3
Pages	1015-1016
DOI	https://doi.org/10.1097/01.HS9.0000847368.92731.fb
Keywords	Hematology
Public URL	https://nottingham-repository.worktribe.com/output/23550306
Publisher URL	https://journals.lww.com/hemasphere/Fulltext/2022/06003/P1125__CELESTIMO__A_PHASE_III_TRIAL_EVALUATING_THE.1015.aspx
Additional Information	Poster presented at EHA2022 Hybrid Congress, 15-17 June 2022